Loading clinical trials...
Loading clinical trials...
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
The investigators will examine the possible synergistic effects of obstructive sleep apnea (OSA) and type II diabetes mellitus (DM) on vascular functioning by performing a two-part investigation: * A cross-sectional study comparing subjects with OSA+DM, OSA only, DM only, and healthy controls. * A three-month randomized placebo-controlled trial of continuous positive airway pressure (CPAP) in subjects with OSA+DM.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
Yes
Brigham & Women's Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Start Date
April 1, 2012
Primary Completion Date
February 1, 2017
Completion Date
February 1, 2017
Last Updated
May 28, 2019
53
ACTUAL participants
Continuous positive airway pressure
DEVICE
Sham continuous positive airway pressure
DEVICE
Lead Sponsor
Sanjay R Patel
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07480161